Learn more about what is involved by downloading our Study Participant Frequently Asked Questions (FAQ) or by contacting the research coordinator.

Download FAQ (PDF 53 KB)

 

MADIT-RIT

MADIT-RIT

Title: MA-RIT: Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy

Status: Enrolling

Study Sponsor: Boston Scientific 

Principal Investigator: Charles Gornick, MD

Study Overview: The overall goal of this trial is to determine if safe and effective ICD device therapy can be provided while at the same time reducing inappropriate therapy. Currently, patients implanted with an ICD have devices that are programmed to treat rhythms that are common to patients that have had a heart attack. It is less clear what the optimal programming is for patents who need an ICD but have not had a heart attack. This study is being conducted to determine the best programming for primary prevention patients to reduce the number of inappropriate therapies (shocks) that may be received from a CRT-D or ICD cardiac device.

This study will be conducted at about 75 centers and enroll approximately 1,500 subjects. Participation in this study is expected to be approximately 12-24 months, and is limited to collecting data at regular ICD checks.

Who do I contact for more information?  Karen Meyer, RN, at 612.863.5855 or email karen.meyer2@allina.com.